SONOMA PHARMACEUTICALS, INC. Cash and Restricted Cash
SONOMA PHARMACEUTICALS, INC. (SNOA) had Cash and Restricted Cash of $5.34 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.34M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.40M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.56M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.04M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $5.34M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.40M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $2.56M 10-Q · filed 2026-02-10 |
| 2025-09-30 | $3.04M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $3.60M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $5.37M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $5.24M 10-Q · filed 2026-02-10 |
| 2024-09-30 | $4.08M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $2.59M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $3.13M 10-K · filed 2026-06-16 |
| 2023-12-31 | $2.41M 10-Q · filed 2025-02-05 |
| 2023-09-30 | $2.14M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $3.54M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $3.82M 10-K · filed 2025-06-17 |
| 2022-12-31 | $2.63M 10-Q · filed 2024-02-08 |
| 2022-09-30 | $3.35M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $5.59M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $7.40M 10-K · filed 2024-06-17 |
| 2021-12-31 | $8.53M 10-Q · filed 2023-02-14 |
| 2021-09-30 | $8.39M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $2.81M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $4.22M 10-K · filed 2023-06-21 |
| 2020-03-31 | $3.69M 10-K · filed 2022-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |